Placebo News and Research

RSS

Researchers rebut theory that antidepressants do not exert any actual effect

A theory that has gained considerable attention in international media, including Newsweek and the CBS broadcast 60 minutes, suggest that antidepressant drugs, such as the SSRIs, do not exert any actual antidepressant effect.

18 Aug 2017

Drug blocked by regulators found to improve quality of life for MS patients

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London.

18 Aug 2017

Research shows probiotics can reduce incidence of sepsis in infants

A research team at the University of Nebraska Medical Center College of Public Health has determined that a special mixture of good bacteria in the body reduced the incidence of sepsis in infants in India by 40 percent at a cost of only $1 per infant.

16 Aug 2017

Experts explore ways to improve safety of care for nursing home residents with dementia

By 2050, the number of people 65 and older with dementia in the United States is expected to nearly triple – from 5 million to more than 13 million – increasing the numbers in assisted living and nursing homes.

16 Aug 2017

Cardiac stem cells from young hearts can make older hearts young, study says

A new study from the Cedars-Sinai Heart Institute, Los Angeles, published by the European Heart Journal, forecasts the use of infusions of cardiac stem cells obtained from young hearts in reversing the process of aging in the human heart.

16 Aug 2017

Cardiac stem cell infusions could help reverse aging process in the heart, study shows

Cardiac stem cell infusions could someday help reverse the aging process in the human heart, making older ones behave younger, according to a new study from the Cedars-Sinai Heart Institute.

14 Aug 2017

Small clinical trial shows promise for treating rare neurodegenerative disease

Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.

11 Aug 2017

Immunotherapy shows promise in treatment of Type 1 diabetes

Around 1.25 million Americans are living with type 1 diabetes and 40,000 new cases are detected each year. In this condition body’s own immune system attacks and damages the insulin-producing β-cells inside the pancreas leading to impaired glucose metabolism in the body. There is no other treatment for this condition than regular painful insulin injections to maintain the normal insulin levels in the body. Type 1 diabetes is currently considered to be incurable.

10 Aug 2017

New review shows potential of Vitamin B3 for preventing melanoma

A new review highlights the potential of nicotinamide (Vitamin B3) for preventing melanoma in high-risk individuals.

9 Aug 2017

Biological bypass found safe for patients with coronary artery disease

A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease, according to a successful trial carried out in Finland.

8 Aug 2017

Extract from red hot peppers boosts metabolic rate, study shows

As we age, managing healthy weight may become more difficult due to a slowing metabolism, however, help may come from a fiery source -- the capsicum pepper.

7 Aug 2017

Diabetes drug shows promise as Parkinson’s treatment

A drug commonly used to treat diabetes could help people living with Parkinson’s disease, say researchers.

7 Aug 2017

Experimental drug protects mice from obesity-related liver disease

A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease.

3 Aug 2017

Researchers develop potential stem cell treatment for several lung conditions

A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis -- often-fatal conditions that affect tens of millions of Americans.

3 Aug 2017

Type 1 diabetes clinical trial reaches halfway point for enrollment and treatment

The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., has reached the halfway point for enrollment and treatment.

28 Jul 2017

New study examines efficacy of extended-release guanfacine in children with chronic tic disorders

A new study assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age who have chronic tic disorders including Tourette's disorder.

26 Jul 2017

New trial shows ketamine's effectiveness to treat geriatric depression

Australian researchers have completed the world's first randomised control trial (RCT) assessing the efficacy and safety of ketamine as a treatment for depression in elderly patients.

24 Jul 2017

People who think they are less active than peers more likely to have shorter lifespan

Would you say that you are physically more active, less active, or about equally active as other people your age? Your answer might be linked to your risk of premature death decades from now - no matter how physically active you actually are, according to research by Stanford scholars Octavia Zahrt and Alia Crum.

20 Jul 2017

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

18 Jul 2017

Placebo News and Research

Researchers rebut theory that antidepressants do not exert any actual effect

Drug blocked by regulators found to improve quality of life for MS patients

Research shows probiotics can reduce incidence of sepsis in infants

Experts explore ways to improve safety of care for nursing home residents with dementia

Cardiac stem cells from young hearts can make older hearts young, study says

Cardiac stem cell infusions could help reverse aging process in the heart, study shows

Small clinical trial shows promise for treating rare neurodegenerative disease

Immunotherapy shows promise in treatment of Type 1 diabetes

New review shows potential of Vitamin B3 for preventing melanoma

Biological bypass found safe for patients with coronary artery disease

Extract from red hot peppers boosts metabolic rate, study shows

Diabetes drug shows promise as Parkinson’s treatment

Experimental drug protects mice from obesity-related liver disease

Researchers develop potential stem cell treatment for several lung conditions

Type 1 diabetes clinical trial reaches halfway point for enrollment and treatment

New study examines efficacy of extended-release guanfacine in children with chronic tic disorders

New trial shows ketamine's effectiveness to treat geriatric depression

People who think they are less active than peers more likely to have shorter lifespan

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News